Загрузка...
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group Study S0202
BACKGROUND: Patients with gallbladder cancer or cholangiocarcinoma usually present with advanced disease and limited treatment options. Based on the common embryologic origin of the exocrine pancreas and gallbladder, coupled with data demonstrating effectiveness of gemcitabine in pancreatic carcinom...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3519425/ https://ncbi.nlm.nih.gov/pubmed/21556747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1657-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|